Guardant Health, Bristol-Myers Squibb to Deploy Liquid Biopsies in Clinical Trials

Nov 16, 2017

|

NEW YORK (GenomeWeb) – Guardant Health said today that it is working with Bristol-Myers Squibb to develop the GuardantOMNI assay, a 500-plus-gene liquid biopsy panel designed to accelerate clinical trials and targeted cancer therapy research.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Breaking News

The Scan

Whirlwind Genetic Genealogy Year

Wired reports on how genetic genealogy's use in forensics has exploded in the year since an arrest in the Golden State Killer case was made.

Getting Through the Backlog

Retraction Watch reports that the increase in retracted papers at a journal is due to more resources there to tackle publication ethics.

Settlement After DNA Testing Questions

New York City has settled with a forensic scientist who was fired after questioning a DNA testing approach used by the medical examiner's office, the New York Times reports.

This Week in Nature

In Nature this week: technique for measuring replication fork movement, WINTHER trial results, and more.

Featured White Papers

BlueBee Data Security & Compliance

The WOLF 'Cuts' Time from CRISPR Workflows

Evaluation of the Oncomine BRCA Research Assay for Variant Detection by Next-Generation Sequencing

Quantitative Clonal Barcode Analysis

Apr

30

Featured Webinar

Novel Methods for Improving De Novo Transcriptome Annotation with Long-Read Transcript Sequencing

This webinar will discuss novel long-read transcript sequencing (LRTseq) methods for transcriptome annotation that could increase the efficiency and accuracy of future sequencing projects.

May

01

Featured Webinar

Virus-Specific Target Capture Coupled with NGS for Rapid and Sensitive Respiratory Virus Detection

This webinar will discuss the benefits of virus-specific target capture combined with next-generation sequencing (NGS) to identify viral infections and conduct comprehensive genomic and transcriptomic interrogation.

May

07

Featured Webinar

Implementing a Multisite Clinical System for Genomics with Best-in-Class Tools: the GenoVic Project

This webinar will discuss the implementation of an enterprise-wide clinical genomics platform that is shared across 10 hospitals and research organizations in the Australian State of Victoria.

May

08

Featured Webinar

OncoBEAM ctDNA Testing for Early Response Prediction and Therapy Surveillance in Melanoma and Pancreatic Cancer

This webinar will present recent evidence that demonstrates how incorporating circulating tumor DNA (ctDNA) assessments into real-world patient management can influence patient care decisions, alter radiographic interpretations, and impact clinical outcomes.

Menu